Filing Details
- Accession Number:
- 0000059478-23-000188
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-15 16:21:12
- Reporting Period:
- 2023-06-14
- Accepted Time:
- 2023-06-15 16:21:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 59478 | Eli Lilly & Co | LLY | Pharmaceutical Preparations (2834) | 350470950 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1702471 | Johna Norton | Lilly Corporate Center Indianapolis IN 46285 | Evp, Global Quality | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-06-14 | 1,647 | $444.29 | 31,761 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-06-15 | 1,647 | $448.00 | 30,114 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 401 | Indirect | 401(k) |
| Common Stock | 1,765 | Indirect | 401(k) - by partner |
| Common Stock | 128 | Indirect | by partner |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 21, 2023.
Billionaire Hedge Funds
